Prognostic significance of TEL/AML1 fusion transcript in childhood B- precursor acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 3, 1998, Pages 190-195

  Takahashi, Yoshiyuki ^a   Horibe, Keizo ^a   Kiyoi, Hitoshi ^a   Miyashita, Yoshiko ^a   Fukuda, Minoru ^a   Mori, Hiroshi ^a   Nozaki, Chika ^a   Hasegawa, Shinji ^a   Kawabe, Takashi ^a   Kato, Koji ^b   Kojima, Seiji ^b   Matuyama, Takaharu ^b   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

Acute lymphoblastic leukemia; Reverse transcription PCR; T(12; 21); TEL; TEL AML1

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD CANCER; CHROMOSOME ABERRATION; GENE EXPRESSION REGULATION; GENE FUSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; JAPAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEOPLASM PROTEINS; NEPRILYSIN; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSCRIPTION, GENETIC;

EID: 0031867826     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199805000-00002     Document Type: Article

References (22)

1. Pui C-H. Childhood leukemias. N Engl J Med 1995;332:1618-30.
2. Rabbits TH. Chromosomal translocations in human cancer. Nature 1994;372:143-9.
3. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993;81:2237-51.
4. Raimondi SC, Williams DL, Callihan T, et al. Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 1986;68:69-75.
5. Golub TR, Barker GF, Bohlander SK, et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995;92:4917-21.
6. Romana SP, Mauchauffe M, Le Coniat M, et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995;85:3662-70.
7. Romana SP, Poirel H, Leconiat M, et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995;86:4263-9.
8. Shurtleff SA, Buijs A, Behm FG, et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995;9:1985-9.
9. Liang D-C, Chou T-B, Chen J-S, et al. High incidence of TEL/AML1 fusion resulting from a cryptic t(12,21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996;10:991-3.
10. McLean TW, Ringold S, Neuberg D, et al. TEL/AML1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 1996;88:4252-8.
11. Rubmitz JE, Shuster JJ, Land VJ, et al. Case-control study suggests a favourable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group Study. Blood 1997;89:1143-6.
12. Rubnitz JE, Downing JR, Pui C-H, et al. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol 1997;15:1150-7.
13. Borkhardt A, Cazzaniga G, Viehmann S, et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood 1997;90:571-7.
14. Rubintz JE, Behm FG, Pui C-H, et al. Genetic studies of childhood lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia 1997;11:1201-6.
15. Miyajima Y, Kato K, Numata S, et al. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 1995;75:2757-61.
16. Golub TR, Barker GF, Lovett M, et al. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994;77:307-16.
17. Miyoshi H, Shimizu K, Kozu T, et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991;88:10431-4.
18. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Komada Y, Ito M, Yazaki M, et al. Treatment outcome of 8511 protocol for standard-risk acute lymphoblastic leukemia in children -Part I: A report from Tokai Pediatric Oncology Study Group. Jpn J Pediatr Hematol 1994;8:90-6.
20. Hongo T, Inoue N, Horibe K, et al. Treatment results of the Tokai-POSG 8610HR pilot protocol for children with high-risk acute lymphoblastic leukemia. Jpn J Pediatr Hematol 1997;11:370-6.
21. Horibe K, Komada Y. Treatment outcome of standard risk acute lymphoblastic leukemia during childhood. Jpn J Pediatr Hematol 1996;10:359-66.
22. Raynaud S, Mauvieux L, Cayuela JM, et al. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 1996;10:1529-30.